Abbott, global health care company, is all set to preview the m2000, its new real-time PCR automated molecular diagnostic system, at the annual American Association for Clinical Chemistry (AACC) meeting in Chicago (July 23-27). Edward Michael, president of Abbott Molecular, said: The m2000 has been designed to help our customers deliver patient test results quickly and efficiently, with extremely accurate results. This innovative system represents our continued commitment to accelerate automation for the clinical molecular laboratory and improve the diagnosis, monitoring and care of patients with infectious diseases and other serious illnesses. The m2000 system comprises two instruments: the Abbott m2000sp and the m2000rt. It links an automated sample preparation instrument (m2000sp) with an integrated real-time PCR amplification and detection instrument (m2000rt) via software to provide automation from sample extraction to the reporting of the final test result. The robotic arm of m2000 eliminates steps such as manual pipetting, reducing hands-on time required to prepare samples for DNA/RNA testing by as much as 75 percent.